510(k) K092181
K092181 is an FDA 510(k) premarket notification submitted by Instrumentation Laboratory CO for the device "HEMOSIL ACUSTAR CARDIOLIPIN IGG, IGM AND IGG AND IGM CONTROLS". The FDA issued a decision of Substantially Equivalent on March 11, 2010. The device falls under product code MID (System, Test, Anticardiolipin Immunological), a Class II device regulated under 21 CFR 866.5660. Instrumentation Laboratory CO has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 11, 2010
- Date Received
- July 21, 2009
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Anticardiolipin Immunological
- Device Class
- Class II
- Regulation Number
- 866.5660
- Review Panel
- IM
- Submission Type